Science Explorer Back to mapMap
Discussion
Researcher · Novo Nordisk (Denmark) · Denmark

Anne‐Sophie Sejling

Anne‐Sophie Sejling publishes mostly in Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery, on topics such as Liver Disease Diagnosis and Treatment, Diabetes Management and Research and Pancreatic function and diabetes.

OpenAlex
World rank
#1,328,250
of 7,710,434 ranked researchers
Rank in Denmark
#10,012
of 43,819
Works
36
Citations
2.7k
Citations per work
73.9
h-index
17
i10-index 20Top 29% in Endocrinology, Diabetes and Metabolism
Anne‐Sophie Sejling

What does Anne‐Sophie Sejling research?

Anne‐Sophie Sejling's work is mostly in Medicine (74%), Biochemistry, Genetics and Molecular Biology (6%).

Health Sciences: 27 works · 74.5% of their workMedicine: 27 works · 74.5% of their workEndocrinology, Diabetes and Metabolism: 9 works · 25.5% of their workEpidemiology: 6 works · 16.3% of their workSurgery: 5 works · 14.3% of their workCardiology and Cardiovascular Medicine: 3 works · 9.2% of their workHepatology: 3 works · 9.2% of their workEverything else: 7 works · 19.4% of their workLife Sciences: 2 works · 6.1% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 6.1% of their workMolecular Biology: 2 works · 6.1% of their workTHEIR WORKAnne‐SophieSejling36works
Life Sciences6%Health Sciences74%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2774.5%
  2. Everything else719.4%
    1. Biochemistry, Genetics and Molecular Biology26.1%
  1. 1Endocrinology, Diabetes and Metabolism26% of their works
  2. 2Epidemiology16% of their works
  3. 3Surgery14% of their works
  4. 4Cardiology and Cardiovascular Medicine9% of their works
  5. 5Hepatology9% of their works
  6. 6Molecular Biology6% of their works

Research topics

Which keywords describe Anne‐Sophie Sejling's research?

The keywords of their largest research topics: Hepatocellular Carcinoma, Glycemic Control, Insulin Therapy, Cardiovascular Disease, NAFLD, NASH, Diabetes and Hypoglycemia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Hepatocellular Carcinoma202 topics
  2. Glycemic Control192 topics
  3. Insulin Therapy192 topics
  4. Cardiovascular Disease172 topics
  5. NAFLD161 topic
  6. NASH161 topic
  7. Diabetes111 topic
  8. Hypoglycemia111 topic
  9. Pancreatic Islets91 topic
  10. ß-Cell Dysfunction91 topic
  11. Cardiovascular Outcomes81 topic
  12. Diagnosis82 topics
  13. Management82 topics
  14. Type 2 Diabetes81 topic
  15. Autonomic Nervous System61 topic
  16. Heart Rate Variability61 topic
  17. AMP-Activated Protein Kinase51 topic
  18. Metformin51 topic
  19. Autoimmune Hepatitis41 topic
  20. Liver Cancer41 topic
  21. Primary Biliary Cirrhosis41 topic
  22. Treatment41 topic

Where does Anne‐Sophie Sejling work?

Anne‐Sophie Sejling's main affiliation in the publication record is Novo Nordisk (Denmark), Denmark.

How many publications and citations does Anne‐Sophie Sejling have?

OpenAlex counts 36 works and 2,661 citations for Anne‐Sophie Sejling, an h-index of 17, ranking #1,328,250 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Anne‐Sophie Sejling. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.